Home › Funds › Rhenman & Partners Asset Management AB › CRL

Rhenman & Partners Asset Management AB position in CRL

CHARLES RIV LABS INTL INC · Health Care

Rhenman & Partners Asset Management AB reported holding 46,800 shares of CRL (CHARLES RIV LABS INTL INC) in its Q3 2026 13F filing — a position valued at US$13.8M, representing 1.53% of its reported portfolio and ranking #23 among its reported holdings. Rhenman & Partners Asset Management AB has disclosed CRL holdings in 10 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)46.80K sh
Reported value held$13.81M
Portfolio Weight1.53%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Rhenman & Partners Asset Management AB's CRL position evolved

Rhenman & Partners Asset Management AB first disclosed a stake in CRL in Q3 2023 at 44,000 shares (US$8.6M). The position peaked in Q3 2026 at 46,800 shares, worth US$13.8M. Across 10 filings, Rhenman & Partners Asset Management AB increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 46,800 shares valued at US$13.8M — a reduction of -10,400 shares quarter over quarter.. Notable position changes include a 67% trim in Q1 2024 (shares fell 24% over the following quarter), a 168% increase in Q2 2024 (shares fell 5% over the following quarter), a 120% increase in Q2 2026 (shares rose 30% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 44.00K $8.62M New
Q4 2023 38.00K $8.98M Reduce
Q1 2024 12.70K $3.44M Reduce
Q2 2024 34.00K $7.02M Add
Q3 2024 37.50K $7.39M Add
Q4 2024 14.85K $2.74M Reduce
Q4 2025 22.00K $4.39M New
Q1 2026 26.00K $4.49M Add
Q2 2026 57.20K $12.97M Add
Q3 2026 46.80K $13.81M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CRL and 13F data

CRL (CHARLES RIV LABS INTL INC) is a Health Care company. 29 other funds we track also report a position in CRL — the largest reported positions include ARIEL INVESTMENTS, LLC (US$352.0M), EARNEST PARTNERS LLC (US$320.7M), Allspring Global Investments Holdings, LLC (US$254.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRL

All CRL fund holders →

FAQ

How long has Rhenman & Partners Asset Management AB held CRL?

Rhenman & Partners Asset Management AB has disclosed CRL holdings in 10 of the last 13 reported quarters, going back to Q3 2023.

What is Rhenman & Partners Asset Management AB's current position in CRL?

As of Q3 2026, Rhenman & Partners Asset Management AB holds 46.80K shares of CRL (CHARLES RIV LABS INTL INC), valued at $13.81M, representing 1.53% of its reported portfolio and ranking #23.

Has Rhenman & Partners Asset Management AB been buying or selling CRL?

In the latest 13F filing (Q3 2026), Rhenman & Partners Asset Management AB reduced its position in CRL. The position peaked in Q3 2026 at 46.80K shares.

Which other funds hold CRL?

Other major institutional holders of CRL include ARIEL INVESTMENTS, LLC, EARNEST PARTNERS LLC, Allspring Global Investments Holdings, LLC, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.